Brandywine Oak Private Wealth’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.33M | Sell |
28,116
-696
| -2% | -$131K | 0.4% | 31 |
|
|
2026
Q1 | $5.68M | Sell |
28,812
-1,773
| -6% | -$342K | 0.48% | 30 |
|
|
2025
Q4 | $5.62M | Sell |
30,585
-1,787
| -6% | -$313K | 0.47% | 31 |
|
|
2025
Q3 | $4.97M | Sell |
32,372
-863
| -3% | -$131K | 0.43% | 31 |
|
|
2025
Q2 | $4.64M | Buy |
33,235
+473
| +1% | +$66.3K | 0.43% | 33 |
|
|
2025
Q1 | $4.82M | Sell |
32,762
-1,063
| -3% | -$154K | 0.47% | 32 |
|
|
2024
Q4 | $4.43M | Buy |
33,825
+22
| +0.1% | +$3.08K | 0.43% | 35 |
|
|
2024
Q3 | $5.27M | Sell |
33,803
-6,412
| -16% | -$1.04M | 0.51% | 32 |
|
|
2024
Q2 | $6.27M | Sell |
40,215
-1,966
| -5% | -$296K | 0.64% | 24 |
|
|
2024
Q1 | $5.72M | Sell |
42,181
-8
| -0% | -$1.06K | 0.6% | 25 |
|
|
2023
Q4 | $5.68M | Sell |
42,189
-191
| -0.5% | -$24.8K | 0.63% | 23 |
|
|
2023
Q3 | $5.74M | Sell |
42,380
-1,583
| -4% | -$216K | 0.67% | 24 |
|
|
2023
Q2 | $6.29M | Sell |
43,963
-816
| -2% | -$120K | 0.7% | 23 |
|
|
2023
Q1 | $6.22M | Buy |
44,779
+28,810
| +180% | +$3.88M | 0.73% | 23 |
|
|
2022
Q4 | $2.17M | Sell |
15,969
-1,820
| -10% | -$228K | 0.27% | 57 |
|
|
2022
Q3 | $1.95M | Sell |
17,789
-632
| -3% | -$80.2K | 0.26% | 61 |
|
|
2022
Q2 | $2.43M | Sell |
18,421
-3
| -0% | -$394 | 0.31% | 48 |
|
|
2022
Q1 | $2.44M | Sell |
18,424
-2,089
| -10% | -$251K | 0.28% | 66 |
|
|
2021
Q4 | $2.39M | Buy |
20,513
+865
| +4% | +$102K | 0.26% | 66 |
|
|
2021
Q3 | $2.35M | Sell |
19,648
-221
| -1% | -$25.7K | 0.27% | 63 |
|
|
2021
Q2 | $2.38M | Buy |
19,869
+1,081
| +6% | +$119K | 0.28% | 60 |
|
|
2021
Q1 | $1.87M | Buy |
18,788
+113
| +0.6% | +$11.4K | 0.28% | 59 |
|
|
2020
Q4 | $1.87M | Buy |
18,675
+120
| +0.6% | +$12.7K | 0.28% | 58 |
|
|
2020
Q3 | $2.03M | Sell |
18,555
-1,586
| -8% | -$176K | 0.34% | 48 |
|
|
2020
Q2 | $2.13M | Buy |
20,141
+796
| +4% | +$82.2K | 0.38% | 46 |
|
|
2020
Q1 | $1.73M | Buy |
19,345
+1,713
| +10% | +$161K | 0.36% | 47 |
|
|
2019
Q4 | $1.76M | Sell |
17,632
-821
| -4% | -$77.3K | 0.32% | 50 |
|
|
2019
Q3 | $1.64M | Sell |
18,453
-804
| -4% | -$69.7K | 0.31% | 53 |
|
|
2019
Q2 | $1.59M | Sell |
19,257
-2,099
| -10% | -$165K | 0.32% | 52 |
|
|
2019
Q1 | $1.73M | Sell |
21,356
-991
| -4% | -$78.1K | 0.36% | 45 |
|
|
2018
Q4 | $1.7M | Buy |
+22,347
| New | +$1.75M | 0.38% | 44 |
|
Other funds holding AZN
EP
IA
Brandywine Oak Private Wealth's AZN Position: Q2 2026 in Review
Brandywine Oak Private Wealth reduced its AstraZeneca (AZN) stake by 2.4% in Q2 2026, selling an estimated $131K and leaving 28,116 shares worth $5.33M. The position accounts for 0.4% of the portfolio, ranked #31.
Brandywine Oak Private Wealth first reported a position in AZN in Q4 2018 and has held it in 31 quarters since. The position peaked at $6.29M in Q2 2023. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Brandywine Oak Private Wealth held 28,116 shares of AstraZeneca worth $5.33M as of Q2 2026.
- Brandywine Oak Private Wealth sold 696 AstraZeneca shares in Q2 2026, an estimated $131K.
- AstraZeneca made up 0.4% of Brandywine Oak Private Wealth's portfolio in Q2 2026, its #31 holding.
- Brandywine Oak Private Wealth first reported a position in AstraZeneca in Q4 2018 and has held it in 31 quarters since.
- Brandywine Oak Private Wealth's AstraZeneca position peaked at $6.29M in Q2 2023.
- 1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Brandywine Oak Private Wealth's 13F filing for Q2 2026, filed 16 Jul 2026.